Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies

Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity in infected and vaccinated subjects. The current gold standard relies on pseudovirus neutralization tests which require sophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zedan, Hadeel T., Yassine, Hadi M., Al-Sadeq, Duaa W., Liu, Na, Qotba, Hamda, Nicolai, Eleonora, Pieri, Massimo, Bernardini, Sergio, Abu-Raddad, Laith J., Nasrallah, Gheyath K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643483/
https://www.ncbi.nlm.nih.gov/pubmed/36347859
http://dx.doi.org/10.1038/s41598-022-21317-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643483/
https://www.ncbi.nlm.nih.gov/pubmed/36347859
http://dx.doi.org/10.1038/s41598-022-21317-x

Ejemplares similares